ROCHE HLDG LTD SPONS Blog | Talkmarkets | Page 1
No data available
No data available

People who follow this stock (33)

Latest Posts

About This Stock More About This Stock
Biopharma Stocks Rally And Gene Therapy Stocks Are Still Hot
Article By: Rod Raynovich
Friday, March 22, 2019 7:17 AM EDT
Mid-Cap biotech stocks ran up today along with a broad market rally in tech stocks with the NAZ up 1.42% and the XLK​ up 2.51%.
In this article: NAZ, RHHBY, BLUE, BIIB, XLK, ACIU
Read
Biotech Stocks Hold After Brief Sell-Off Last Week…Updates
Article By: Rod Raynovich
Sunday, March 10, 2019 12:22 PM EDT
Biotech ETFs lost momentum last week but held near term support near the 20 Day moving average. Now that most companies have reported we should not expect fundamentals to create volatility.
In this article: BMY, MRK, RHHBY, IBB, REGN, CELG, GILD, VRTX, XBI, ABBV
Read
Small Cap Biotechs Lead The Market In 2019 Up 20% YTD
Article By: Rod Raynovich
Thursday, February 28, 2019 12:20 PM EDT
Gene Therapy stocks soar on Spark (ONCE) Deal: BLUE, CRSP, RARE; and XBI up 4.2%.
In this article: ONCE, RARE, DHR, GE, XBI, BLUE, CRSP, IWM, XLV, MRK, RHHBY, BMY, CELG, LOXO, LLY, GNMK, AMRN, TDOC
Read
Roche Acquires Spark Therapeutics For $114.50 Per Share, A 122% Premium
Article By: The Fly
Monday, February 25, 2019 7:23 AM EDT
Spark Therapeutics announced that it has entered into a definitive merger agreement for Roche to fully acquire Spark Therapeutics at a price of $114.50 per share in an all-cash transaction.
In this article: RHHBY, ONCE
Read
3 Drug/Biotech Stocks In Focus On World Alzheimer's Day
Article By: Zacks Investment Research
Friday, September 21, 2018 2:57 PM EDT
Here we take a look at companies with promising candidates in their pipeline for Alzheimer’s Disease (AD).
In this article: RHHBY, BIIB Also: AGN
Read

PARTNER HEADLINES

Latest Tweets for $RHHBY

No tweets yet!